| scholarly article | Q13442814 |
| P50 | author | Carmen Velasco | Q54449619 |
| José Manuel Rodríguez Martínez | Q54449621 | ||
| Luis Martínez Martínez | Q57053577 | ||
| Alvaro Pascual | Q60594097 | ||
| Isabel García | Q64149064 | ||
| P2093 | author name string | I García | |
| M E Cano | |||
| P2860 | cites work | Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe | Q33556074 |
| Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group | Q33696010 | ||
| Pharmacokinetics and pharmacodynamics of fluoroquinolones | Q33770078 | ||
| The safety profile of the fluoroquinolones. | Q34005865 | ||
| Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae | Q34434110 | ||
| The worldwide emergence of plasmid-mediated quinolone resistance | Q34569740 | ||
| Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China | Q35102456 | ||
| The mutant selection window and antimicrobial resistance | Q35153856 | ||
| Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents | Q35277130 | ||
| Mechanisms of resistance to quinolones | Q36155441 | ||
| Common region CR1 for expression of antibiotic resistance genes | Q41474615 | ||
| Strategies to minimize the development of antibiotic resistance | Q41555987 | ||
| In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase | Q42059972 | ||
| Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1. | Q42072245 | ||
| Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase | Q44367877 | ||
| Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli | Q44624656 | ||
| Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose | Q44809903 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Interaction of plasmid and host quinolone resistance | Q73167556 | ||
| Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids | Q83211402 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Enterobacteriaceae | Q380136 |
| quinolones | Q426549 | ||
| P304 | page(s) | 2236-2239 | |
| P577 | publication date | 2007-04-02 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1 | |
| P478 | volume | 51 |
| Q36893628 | Accelerated evolution of resistance in multidrug environments |
| Q41338772 | Alteration of GyrA amino acid required for ciprofloxacin resistance in Klebsiella pneumoniae isolates in China |
| Q92739401 | Dissemination of Quinolone-Resistant Escherichia coli in the Norwegian Broiler and Pig Production Chains and Possible Persistence in the Broiler Production Environment |
| Q33792926 | Drug interactions and the evolution of antibiotic resistance |
| Q37896674 | Emergence and spread of antibiotic resistance following exposure to antibiotics |
| Q36173899 | Fluoroquinolone Resistance in Salmonella and the Utility of Pefloxacin Disk Diffusion [corrected]. |
| Q37643475 | Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin |
| Q43207261 | Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals |
| Q37392904 | Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection |
| Q42706278 | In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. |
| Q50043202 | International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries |
| Q42201141 | Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. |
| Q36225422 | Mechanisms of drug resistance: quinolone resistance |
| Q36333597 | Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals |
| Q38986466 | Molecular analysis of ciprofloxacin resistance mechanisms in Malaysian ESBL-producing Klebsiella pneumoniae isolates and development of mismatch amplification mutation assays (MAMA) for rapid detection of gyrA and parC mutations. |
| Q40788996 | Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies |
| Q41337698 | Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. |
| Q34888920 | Plasmid-mediated quinolone resistance |
| Q36229100 | Plasmid-mediated quinolone resistance genes and antibiotic residues in wastewater and soil adjacent to swine feedlots: potential transfer to agricultural lands |
| Q30240591 | Plasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries. |
| Q24645356 | Plasmid-mediated quinolone resistance: a multifaceted threat |
| Q34460490 | Prevalence of plasmid-mediated quinolone resistance and aminoglycoside resistance determinants among carbapeneme non-susceptible Enterobacter cloacae |
| Q37072043 | Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period |
| Q34238560 | Prevalence of plasmid-mediated quinolone resistance genes among ciprofloxacin-nonsusceptible Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in Korea |
| Q57742794 | Prevalence of qnr genes among extended-spectrum β-lactamase-producing enterobacterial isolates in Barcelona, Spain |
| Q40324905 | Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications |
| Q39737709 | Quinolone resistance: much more than predicted. |
| Q21132017 | Resistance determinants and mobile genetic elements of an NDM-1-encoding Klebsiella pneumoniae strain |
| Q27667906 | Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor |
| Q38906198 | Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance |
Search more.